Onderzoeker
Hendrik Jan Thibaut
- Disciplines:Microbiologie, Systeembiologie, Laboratoriumgeneeskunde
Affiliaties
- Laboratorium Virologie en Chemotherapie (Rega Instituut) (Afdeling)
Lid
Vanaf1 okt 2006 → Heden
Projecten
1 - 1 of 1
- Het onrafelen van resistentiemechanismen tegen kinaseremmers via op CRISPR gebaseerde gain-of-function-mutagenese.Vanaf12 jul 2022 → HedenFinanciering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
31 - 40 van 64
- Limited evolution of the yellow fever virus 17d in a mouse infection model.(2019)
Auteurs: Niraj Mishra, Bram Vrancken, Hendrik Jan Thibaut, Philippe Lemey, Johan Neyts, Kai Dallmeier
Pagina's: 1734 - 1746 - The life cycle of non-polio enteroviruses and how to target it(2018)
Auteurs: Jim Baggen, Hendrik Jan Thibaut, Jeroen RPM Strating, Frank JM van Kuppeveld
Pagina's: 368 - 381 - The life cycle of non-polio enteroviruses and how to target it (vol 16, pg 368, 2018)(2018)
Auteurs: Jim Baggen, Hendrik Jan Thibaut, Jeroen RPM Strating, Frank JM van Kuppeveld
Pagina's: 391 - 391 - Role of enhanced receptor engagement in the evolution of a pandemic acute hemorrhagic conjunctivitis virus(2018)
Auteurs: Jim Baggen, Daniel L Hurdiss, Georg Zocher, Nitesh Mistry, Richard W Robert, Jasper J Slager, Hongbo Guo, Arno LW van Vliet, Maryam Wahedi, Kimberley Benschop, et al.
Pagina's: 397 - 402 - PLA2G16 represents a switch between entry and clearance of Picornaviridae(2017)
Auteurs: Jacqueline Staring, Eleonore von Castelmur, Vincent A Blomen, Lisa G van den Hengel, Markus Brockmann, Jim Baggen, Hendrik Jan Thibaut, Joppe Nieuwenhuis, Hans Janssen, Frank JM van Kuppeveld, et al.
Pagina's: 412 - + - Hydantoin: The mechanism of its in vitro anti-enterovirus activity revisited(2016)
Auteurs: Aloys Tijsma, Hendrik Jan Thibaut, Kai Dallmeier, Johan Neyts
Pagina's: 106 - 109 - 9-Norbornyl-6-chloropurine (NCP) induces cell death through GSH depletion-associated ER stress and mitochondrial dysfunction(2016)
Auteurs: Hendrik Jan Thibaut, Johan Neyts
Pagina's: 223 - 235 - Enterovirus D68 receptor requirements unveiled by haploid genetics (vol 113, pg 1399, 2016)(2016)
Auteurs: Jim Baggen, Hendrik Jan Thibaut, Jacqueline Staring, Lucas T Jae, Yue Liu, Hongbo Guo, Jasper J Slager, Jost W de Bruin, Arno LW van Vliet, Vincent A Blomen, et al.
Pagina's: E1588 - E1588 - Enterovirus D68 receptor requirements unveiled by haploid genetics(2016)
Auteurs: Jim Baggen, Hendrik Jan Thibaut
Pagina's: 1399 - 1404 - Toward antiviral therapy/prophylaxis for rhinovirus-induced exacerbations of chronic obstructive pulmonary disease: challenges, opportunities, and strategies(2016)
Auteurs: Hendrik Jan Thibaut, Marc Decramer, Johan Neyts
Pagina's: 21 - 33
Patenten
1 - 10 van 10
- Coronavirus vaccines (Inventor)
- Novel compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)
- Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- 1,3-di-oxo-indene derivative, pharmaceutically acceptable salt or optical isomer thereof, preparation method thereof, and pharmaceutical composition containing same as an antiviral, active ingredient (Inventor)
- Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases (Inventor)